These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 9288699)

  • 1. The Postmenopausal Estrogen/Progestin Interventions Study: primary outcomes in adherent women.
    Barrett-Connor E; Slone S; Greendale G; Kritz-Silverstein D; Espeland M; Johnson SR; Waclawiw M; Fineberg SE
    Maturitas; 1997 Jul; 27(3):261-74. PubMed ID: 9288699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI.
    JAMA; 1996 Nov; 276(17):1389-96. PubMed ID: 8892713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators.
    Greendale GA; Reboussin BA; Sie A; Singh HR; Olson LK; Gatewood O; Bassett LW; Wasilauskas C; Bush T; Barrett-Connor E
    Ann Intern Med; 1999 Feb; 130(4 Pt 1):262-9. PubMed ID: 10068383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of postmenopausal hormone therapy on glucose and insulin concentrations. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions.
    Espeland MA; Hogan PE; Fineberg SE; Howard G; Schrott H; Waclawiw MA; Bush TL
    Diabetes Care; 1998 Oct; 21(10):1589-95. PubMed ID: 9773716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.
    Shumaker SA; Legault C; Kuller L; Rapp SR; Thal L; Lane DS; Fillit H; Stefanick ML; Hendrix SL; Lewis CE; Masaki K; Coker LH;
    JAMA; 2004 Jun; 291(24):2947-58. PubMed ID: 15213206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmenopausal hormone therapy and change in mammographic density.
    Greendale GA; Reboussin BA; Slone S; Wasilauskas C; Pike MC; Ursin G
    J Natl Cancer Inst; 2003 Jan; 95(1):30-7. PubMed ID: 12509398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women.
    Koh KK; Jin DK; Yang SH; Lee SK; Hwang HY; Kang MH; Kim W; Kim DS; Choi IS; Shin EK
    Circulation; 2001 Apr; 103(15):1961-6. PubMed ID: 11306524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen, progestogens and cardiovascular risk.
    Stefanick ML
    J Reprod Med; 1999 Feb; 44(2 Suppl):221-6. PubMed ID: 11392036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of estrogen with and without progestin on urinary incontinence.
    Hendrix SL; Cochrane BB; Nygaard IE; Handa VL; Barnabei VM; Iglesia C; Aragaki A; Naughton MJ; Wallace RB; McNeeley SG
    JAMA; 2005 Feb; 293(8):935-48. PubMed ID: 15728164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism.
    Lobo RA; Bush T; Carr BR; Pickar JH
    Fertil Steril; 2001 Jul; 76(1):13-24. PubMed ID: 11438314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate.
    Pickar JH; Yeh I; Wheeler JE; Cunnane MF; Speroff L
    Fertil Steril; 2001 Jul; 76(1):25-31. PubMed ID: 11438315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial.
    Greendale GA; Reboussin BA; Hogan P; Barnabei VM; Shumaker S; Johnson S; Barrett-Connor E
    Obstet Gynecol; 1998 Dec; 92(6):982-8. PubMed ID: 9840563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Half-dose and Standard-dose Conjugated Equine Estrogens Combined with Natural Progesterone or Dydrogesterone on Components of Metabolic Syndrome in Healthy Postmenopausal Women: A Randomized Controlled Trial.
    Xue W; Deng Y; Wang YF; Sun AJ
    Chin Med J (Engl); 2016 Dec; 129(23):2773-2779. PubMed ID: 27900987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate: two-year substudy results.
    Pickar JH; Yeh IT; Wheeler JE; Cunnane MF; Speroff L
    Fertil Steril; 2003 Nov; 80(5):1234-40. PubMed ID: 14607581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of continuous medroxyprogesterone acetate on lipoprotein metabolism in postmenopausal women receiving estrogen.
    Wakatsuki A; Sagara Y
    Maturitas; 1996 Aug; 25(1):35-44. PubMed ID: 8887307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin, transdermal patch, and oral estrogen-progestogen preparation in early-postmenopausal hypercholesterolemic women: a randomized, placebo-controlled clinical trial.
    Vigna GB; Donegà P; Zanca R; Barban A; Passaro A; Pansini F; Bonaccorsi G; Mollica G; Fellin R
    Metabolism; 2002 Nov; 51(11):1463-70. PubMed ID: 12404199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin.
    Heiss G; Wallace R; Anderson GL; Aragaki A; Beresford SA; Brzyski R; Chlebowski RT; Gass M; LaCroix A; Manson JE; Prentice RL; Rossouw J; Stefanick ML;
    JAMA; 2008 Mar; 299(9):1036-45. PubMed ID: 18319414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of estrogen plus progestin on menopausal symptoms in women with systemic lupus erythematosus: a randomized, double-blind, controlled trial.
    Cravioto MD; Durand-Carbajal M; Jiménez-Santana L; Lara-Reyes P; Seuc AH; Sánchez-Guerrero J
    Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1654-63. PubMed ID: 22127965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.